Rebuilding cancer metastasis in the mouse

Molecular Oncology

Volumn 7, Issue 2, 2013, Pages 283-296

  Saxena, Meera ^a   Christofori, Gerhard ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Cancer; Cell invasion; Cell migration; Knockout mice; Metastasis; Mouse models; Transgenic mice; Tumor progression

Indexed keywords

BREAST CANCER; CANCER CELL; CANCER TRANSPLANTATION; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; EPITHELIAL MESENCHYMAL TRANSITION; EXPERIMENTAL MOUSE; GENE EXPRESSION PROFILING; GENETIC ENGINEERING; GENETIC VARIABILITY; LUNG CANCER; METASTASIS; MICROMETASTASIS; NONHUMAN; ORTHOTOPIC TRANSPLANTATION; PANCREAS CANCER; PENETRANCE; POSITRON EMISSION TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; TRANSGENIC MOUSE; TROPISM; TUMOR MICROENVIRONMENT; XENOTRANSPLANTATION;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 84875810421     PISSN: 15747891     EISSN: 18780261     Source Type: Journal    
DOI: 10.1016/j.molonc.2013.02.009     Document Type: Review

References (133)

1. Aguirre A.J., Bardeesy N., Sinha M., Lopez L., Tuveson D.A., Horner J., Redston M.S., DePinho R.A. Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes & Development 2003, 17:3112-3126.
2. Ahmad I., Sansom O.J., Leung H.Y. Advances in mouse models of prostate cancer. Expert Reviews in Molecular Medicine 2008, 10:e16.
3. Arguello F., Baggs R.B., Frantz C.N. A murine model of experimental metastasis to bone and bone marrow. Cancer Research 1988, 48:6876-6881.
4. Banys M., Krawczyk N., Becker S., Jakubowska J., Staebler A., Wallwiener D., Fehm T., Rothmund R. The influence of removal of primary tumor on incidence and phenotype of circulating tumor cells in primary breast cancer. Breast Cancer Research and Treatment 2012, 132:121-129.
5. Berghmans S., Jette C., Langenau D., Hsu K., Stewart R., Look T., Kanki J.P. Making waves in cancer research: new models in the zebrafish. Biotechniques 2005, 39:227-237.
6. Berx G., Raspe E., Christofori G., Thiery J.P., Sleeman J.P. Pre-EMTing metastasis? recapitulation of morphogenetic processes in cancer. Clinical & Experimental Metastasis 2007, 24:587-597.
7. Blouin S., Basle M.F., Chappard D. Rat models of bone metastases. Clinical & Experimental Metastasis 2005, 22:605-614.
8. Bobek V., Kolostova K., Pinterova D., Kacprzak G., Adamiak J., Kolodziej J., Boubelik M., Kubecova M., Hoffman R.M. A clinically relevant, syngeneic model of spontaneous, highly metastatic B16 mouse melanoma. Anticancer Research 2010, 30:4799-4803.
9. Bos P.D., Zhang X.H., Nadal C., Shu W., Gomis R.R., Nguyen D.X., Minn A.J., van de Vijver M.J., Gerald W.L., Foekens J.A., Massague J. Genes that mediate breast cancer metastasis to the brain. Nature 2009, 459:1005-1009.
10. Boyden S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. The Journal of Experimental Medicine 1962, 115:453-466.
11. Brannan C.I., Perkins A.S., Vogel K.S., Ratner N., Nordlund M.L., Reid S.W., Buchberg A.M., Jenkins N.A., Parada L.F., Copeland N.G. Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes & Development 1994, 8:1019-1029.
12. Brodie S.G., Xu X., Qiao W., Li W.M., Cao L., Deng C.X. Multiple genetic changes are associated with mammary tumorigenesis in Brca1 conditional knockout mice. Oncogene 2001, 20:7514-7523.
13. Cabioglu N., Summy J., Miller C., Parikh N.U., Sahin A.A., Tuzlali S., Pumiglia K., Gallick G.E., Price J.E. CXCL-12/stromal cell-derived factor-1alpha transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation. Cancer Research 2005, 65:6493-6497.
14. Cailleau R., Young R., Olive M., Reeves W.J. Breast tumor cell lines from pleural effusions. Journal of the National Cancer Institute 1974, 53:661-674.
15. Carbonell W.S., Ansorge O., Sibson N., Muschel R. The vascular basement membrane as "soil" in brain metastasis. PloS One 2009, 4:e5857.
16. Cespedes M.V., Casanova I., Parreno M., Mangues R. Mouse models in oncogenesis and cancer therapy. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2006, 8:318-329.
17. Chaffer C.L., Weinberg R.A. A perspective on cancer cell metastasis. Science 2011, 331:1559-1564.
18. Chiang A.C., Massague J. Molecular basis of metastasis. The New England Journal of Medicine 2008, 359:2814-2823.
19. Condeelis J., Segall J.E. Intravital imaging of cell movement in tumours. Nature Reviews Cancer 2003, 3:921-930.
20. de Seranno S., Meuwissen R. Progress and applications of mouse models for human lung cancer. The European Respiratory Journal: Official Journal of the European Society for Clinical Respiratory Physiology 2010, 35:426-443.
21. DeNardo D.G., Barreto J.B., Andreu P., Vasquez L., Tawfik D., Kolhatkar N., Coussens L.M. CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell 2009, 16:91-102.
22. Derksen P.W., Liu X., Saridin F., van der Gulden H., Zevenhoven J., Evers B., van Beijnum J.R., Griffioen A.W., Vink J., Krimpenfort P., Peterse J.L., Cardiff R.D., Berns A., Jonkers J. Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. Cancer Cell 2006, 10:437-449.
23. Ding Z., Wu C.J., Chu G.C., Xiao Y., Ho D., Zhang J., Perry S.R., Labrot E.S., Wu X., Lis R., Hoshida Y., Hiller D., Hu B., Jiang S., Zheng H., Stegh A.H., Scott K.L., Signoretti S., Bardeesy N., Wang Y.A., Hill D.E., Golub T.R., Stampfer M.J., Wong W.H., Loda M., Mucci L., Chin L., DePinho R.A. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression. Nature 2011, 470:269-273.
24. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
25. Duan W., Gabril M.Y., Moussa M., Chan F.L., Sakai H., Fong G., Xuan J.W. Knockin of SV40 Tag oncogene in a mouse adenocarcinoma of the prostate model demonstrates advantageous features over the transgenic model. Oncogene 2005, 24:1510-1524.
26. Dubey P., Su H., Adonai N., Du S., Rosato A., Braun J., Gambhir S.S., Witte O.N. Quantitative imaging of the T cell antitumor response by positron-emission tomography. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:1232-1237.
27. DuPage M., Dooley A.L., Jacks T. Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase. Nature Protocols 2009, 4:1064-1072.
28. Eckhardt B.L., Parker B.S., van Laar R.K., Restall C.M., Natoli A.L., Tavaria M.D., Stanley K.L., Sloan E.K., Moseley J.M., Anderson R.L. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix. Molecular Cancer Research: MCR 2005, 3:1-13.
29. Egeblad M., Ewald A.J., Askautrud H.A., Truitt M.L., Welm B.E., Bainbridge E., Peeters G., Krummel M.F., Werb Z. Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Disease Models & Mechanisms 2008, 1:155-167. discussion 165.
30. Ewing J. Neoplastic Diseases: a Treatise on Tumours 1928, By James Ewing, A.M., M.D., Sc.D., Professor of Pathology at Cornell University Medical College, N.Y.; Pathologist to the Memorial Hospital. Third edition. Royal 8vo. Pp. 1127, with 546 illustrations, W. B. Saunders Co. Ltd, Philadelphia and London, 63s. net. British Journal of Surgery 16, 174-175.
31. Fantozzi A., Christofori G. Mouse models of breast cancer metastasis. Breast Cancer Research: BCR 2006, 8:212.
32. Farina K.L., Wyckoff J.B., Rivera J., Lee H., Segall J.E., Condeelis J.S., Jones J.G. Cell motility of tumor cells visualized in living intact primary tumors using green fluorescent protein. Cancer Research 1998, 58:2528-2532.
33. Faust N., Varas F., Kelly L.M., Heck S., Graf T. Insertion of enhanced green fluorescent protein into the lysozyme gene creates mice with green fluorescent granulocytes and macrophages. Blood 2000, 96:719-726.
34. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nature Reviews Cancer 2003, 3:453-458.
35. Fidler I.J., Kripke M.L. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977, 197:893-895.
36. Firestone B. The challenge of selecting the 'right' in vivo oncology pharmacology model. Current Opinion in Pharmacology 2010, 10:391-396.
37. Francia G., Cruz-Munoz W., Man S., Xu P., Kerbel R.S. Mouse models of advanced spontaneous metastasis for experimental therapeutics. Nature Reviews Cancer 2011, 11:135-141.
38. Frese K.K., Tuveson D.A. Maximizing mouse cancer models. Nature Reviews Cancer 2007, 7:645-658.
39. Garabedian E.M., Humphrey P.A., Gordon J.I. A transgenic mouse model of metastatic prostate cancer originating from neuroendocrine cells. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:15382-15387.
40. Gingrich J.R., Barrios R.J., Kattan M.W., Nahm H.S., Finegold M.J., Greenberg N.M. Androgen-independent prostate cancer progression in the TRAMP model. Cancer Research 1997, 57:4687-4691.
41. Gonzalez F.J. Cytochrome P450 humanised mice. Human Genomics 2004, 1:300-306.
42. Greenberg N.M., DeMayo F., Finegold M.J., Medina D., Tilley W.D., Aspinall J.O., Cunha G.R., Donjacour A.A., Matusik R.J., Rosen J.M. Prostate cancer in a transgenic mouse. Proceedings of the National Academy of Sciences of the United States of America 1995, 92:3439-3443.
43. Grippo P.J., Tuveson D.A. Deploying mouse models of pancreatic cancer for chemoprevention studies. Cancer Prevention Research (Philadelphia) 2010, 3:1382-1387.
44. Guerra C., Mijimolle N., Dhawahir A., Dubus P., Barradas M., Serrano M., Campuzano V., Barbacid M. Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context. Cancer Cell 2003, 4:111-120.
45. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Molecular and Cellular Biology 1992, 12:954-961.
46. Hanahan D. Heritable formation of pancreatic beta-cell tumours in transgenic mice expressing recombinant insulin/simian virus 40 oncogenes. Nature 1985, 315:115-122.
47. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
48. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
49. Harms J.F., Welch D.R. MDA-MB-435 human breast carcinoma metastasis to bone. Clinical & Experimental Metastasis 2003, 20:327-334.
50. Hingorani S.R., Petricoin E.F., Maitra A., Rajapakse V., King C., Jacobetz M.A., Ross S., Conrads T.P., Veenstra T.D., Hitt B.A., Kawaguchi Y., Johann D., Liotta L.A., Crawford H.C., Putt M.E., Jacks T., Wright C.V., Hruban R.H., Lowy A.M., Tuveson D.A. Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 2003, 4:437-450.
51. Hubbard G.B., Wood D.H., Butcher W.I. Mammary carcinoma with metastasis in a rhesus monkey (Macaca mulatta). Veterinary Pathology 1984, 21:531-533.
52. Hung K.E., Maricevich M.A., Richard L.G., Chen W.Y., Richardson M.P., Kunin A., Bronson R.T., Mahmood U., Kucherlapati R. Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment. Proceedings of the National Academy of Sciences of the United States of America 2010, 107:1565-1570.
53. Husemann Y., Geigl J.B., Schubert F., Musiani P., Meyer M., Burghart E., Forni G., Eils R., Fehm T., Riethmuller G., Klein C.A. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
54. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., Weinberg R.A. Effects of an Rb mutation in the mouse. Nature 1992, 359:295-300.
55. Jacks T., Remington L., Williams B.O., Schmitt E.M., Halachmi S., Bronson R.T., Weinberg R.A. Tumor spectrum analysis in p53-mutant mice. Current Biology: CB 1994, 4:1-7.
56. Jacks T., Shih T.S., Schmitt E.M., Bronson R.T., Bernards A., Weinberg R.A. Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genetics 1994, 7:353-361.
57. Jackson E.L., Willis N., Mercer K., Bronson R.T., Crowley D., Montoya R., Jacks T., Tuveson D.A. Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes & Development 2001, 15:3243-3248.
58. Jenkins D.E., Oei Y., Hornig Y.S., Yu S.F., Dusich J., Purchio T., Contag P.R. Bioluminescent imaging (BLI) to improve and refine traditional murine models of tumor growth and metastasis. Clinical & Experimental Metastasis 2003, 20:733-744.
59. Jin K., Teng L., Shen Y., He K., Xu Z., Li G. Patient-derived human tumour tissue xenografts in immunodeficient mice: a systematic review. Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2010, 12:473-480.
60. Jonkers J., Berns A. Conditional mouse models of sporadic cancer. Nature Reviews Cancer 2002, 2:251-265.
61. Jonkers J., Derksen P.W. Modeling metastatic breast cancer in mice. Journal of Mammary Gland Biology and Neoplasia 2007, 12:191-203.
62. Kang Y., Siegel P.M., Shu W., Drobnjak M., Kakonen S.M., Cordon-Cardo C., Guise T.A., Massague J. A multigenic program mediating breast cancer metastasis to bone. Cancer Cell 2003, 3:537-549.
63. Kaplan R.N., Rafii S., Lyden D. Preparing the "soil": the premetastatic niche. Cancer Research 2006, 66:11089-11093.
64. Kaplan R.N., Riba R.D., Zacharoulis S., Bramley A.H., Vincent L., Costa C., MacDonald D.D., Jin D.K., Shido K., Kerns S.A., Zhu Z., Hicklin D., Wu Y., Port J.L., Altorki N., Port E.R., Ruggero D., Shmelkov S.V., Jensen K.K., Rafii S., Lyden D. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 2005, 438:820-827.
65. Khanna C., Hunter K. Modeling metastasis in vivo. Carcinogenesis 2005, 26:513-523.
66. Kim M.J., Cardiff R.D., Desai N., Banach-Petrosky W.A., Parsons R., Shen M.M., Abate-Shen C. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:2884-2889.
67. Klein C.A. Parallel progression of primary tumours and metastases. Nature Reviews Cancer 2009, 9:302-312.
68. Klezovitch O., Chevillet J., Mirosevich J., Roberts R.L., Matusik R.J., Vasioukhin V. Hepsin promotes prostate cancer progression and metastasis. Cancer Cell 2004, 6:185-195.
69. Kuperwasser C., Chavarria T., Wu M., Magrane G., Gray J.W., Carey L., Richardson A., Weinberg R.A. Reconstruction of functionally normal and malignant human breast tissues in mice. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:4966-4971.
70. Kuperwasser C., Dessain S., Bierbaum B.E., Garnet D., Sperandio K., Gauvin G.P., Naber S.P., Weinberg R.A., Rosenblatt M. A mouse model of human breast cancer metastasis to human bone. Cancer Research 2005, 65:6130-6138.
71. Lee E.Y., Chang C.Y., Hu N., Wang Y.C., Lai C.C., Herrup K., Lee W.H., Bradley A. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 1992, 359:288-294.
72. Lee H., Lin E.C., Liu L., Smith J.W. Gene expression profiling of tumor xenografts: in vivo analysis of organ-specific metastasis. International Journal of Cancer 2003, 107:528-534.
73. Lelekakis M., Moseley J.M., Martin T.J., Hards D., Williams E., Ho P., Lowen D., Javni J., Miller F.R., Slavin J., Anderson R.L. A novel orthotopic model of breast cancer metastasis to bone. Clinical & Experimental Metastasis 1999, 17:163-170.
74. Lifsted T., Le Voyer T., Williams M., Muller W., Klein-Szanto A., Buetow K.H., Hunter K.W. Identification of inbred mouse strains harboring genetic modifiers of mammary tumor age of onset and metastatic progression. International Journal of Cancer 1998, 77:640-644.
75. Lin E.Y., Nguyen A.V., Russell R.G., Pollard J.W. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. The Journal of Experimental Medicine 2001, 193:727-740.
76. Lin S.C., Lee K.F., Nikitin A.Y., Hilsenbeck S.G., Cardiff R.D., Li A., Kang K.W., Frank S.A., Lee W.H., Lee E.Y. Somatic mutation of p53 leads to estrogen receptor alpha-positive and -negative mouse mammary tumors with high frequency of metastasis. Cancer Research 2004, 64:3525-3532.
77. Lokman N.A., Elder A.S., Ricciardelli C., Oehler M.K. Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. International Journal of Molecular Sciences 2012, 13:9959-9970.
78. Lopez J.I., Camenisch T.D., Stevens M.V., Sands B.J., McDonald J., Schroeder J.A. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Research 2005, 65:6755-6763.
79. Lorger M., Felding-Habermann B. Capturing changes in the brain microenvironment during initial steps of breast cancer brain metastasis. The American Journal of Pathology 2010, 176:2958-2971.
80. Macleod K.F., Jacks T. Insights into cancer from transgenic mouse models. The Journal of Pathology 1999, 187:43-60.
81. Maddison K., Clarke A.R. New approaches for modelling cancer mechanisms in the mouse. The Journal of Pathology 2005, 205:181-193.
82. Maglione J.E., Moghanaki D., Young L.J., Manner C.K., Ellies L.G., Joseph S.O., Nicholson B., Cardiff R.D., MacLeod C.L. Transgenic Polyoma middle-T mice model premalignant mammary disease. Cancer Research 2001, 61:8298-8305.
83. Maroulakou I.G., Oemler W., Naber S.P., Tsichlis P.N. Akt1 ablation inhibits, whereas Akt2 ablation accelerates, the development of mammary adenocarcinomas in mouse mammary tumor virus (MMTV)-ErbB2/neu and MMTV-polyoma middle T transgenic mice. Cancer Research 2007, 67:167-177.
84. McClatchey A.I. Modeling metastasis in the mouse. Oncogene 1999, 18:5334-5339.
85. Meuwissen R., Linn S.C., van der Valk M., Mooi W.J., Berns A. Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene. Oncogene 2001, 20:6551-6558.
86. Minn A.J., Gupta G.P., Siegel P.M., Bos P.D., Shu W., Giri D.D., Viale A., Olshen A.B., Gerald W.L., Massague J. Genes that mediate breast cancer metastasis to lung. Nature 2005, 436:518-524.
87. Muller W.J., Sinn E., Pattengale P.K., Wallace R., Leder P. Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 1988, 54:105-115.
88. Muraoka R.S., Koh Y., Roebuck L.R., Sanders M.E., Brantley-Sieders D., Gorska A.E., Moses H.L., Arteaga C.L. Increased malignancy of Neu-induced mammary tumors overexpressing active transforming growth factor beta1. Molecular and Cellular Biology 2003, 23:8691-8703.
89. Muraoka-Cook R.S., Kurokawa H., Koh Y., Forbes J.T., Roebuck L.R., Barcellos-Hoff M.H., Moody S.E., Chodosh L.A., Arteaga C.L. Conditional overexpression of active transforming growth factor beta1 in vivo accelerates metastases of transgenic mammary tumors. Cancer Research 2004, 64:9002-9011.
90. Naumov G.N., Wilson S.M., MacDonald I.C., Schmidt E.E., Morris V.L., Groom A.C., Hoffman R.M., Chambers A.F. Cellular expression of green fluorescent protein, coupled with high-resolution in vivo videomicroscopy, to monitor steps in tumor metastasis. Journal of Cell Science 1999, 112(Pt 12):1835-1842.
91. Nguyen D.X., Massague J. Genetic determinants of cancer metastasis. Nature Reviews Genetics 2007, 8:341-352.
92. Niu H.X., Du T., Xu Z.F., Zhang X.K., Wang R.G. Role of wild type p53 and double suicide genes in interventional therapy of liver cancer in rabbits. Acta Cirurgica Brasileira/Sociedade Brasileira para Desenvolvimento Pesquisa em Cirurgia 2012, 27:522-528.
93. Nobes C.D., Hall A. Rho GTPases control polarity, protrusion, and adhesion during cell movement. The Journal of Cell Biology 1999, 144:1235-1244.
94. Orimo A., Gupta P.B., Sgroi D.C., Arenzana-Seisdedos F., Delaunay T., Naeem R., Carey V.J., Richardson A.L., Weinberg R.A. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell 2005, 121:335-348.
95. Ottewell P.D., Coleman R.E., Holen I. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Research and Treatment 2006, 96:101-113.
96. Paget S. The distribution of secondary growths in cancer of the breast. 1889. Cancer and Metastasis Reviews 1989, 8:98-101.
97. Palmiter R.D., Brinster R.L. Germ-line transformation of mice. Annual Review of Genetics 1986, 20:465-499.
98. Podsypanina K., Du Y.C., Jechlinger M., Beverly L.J., Hambardzumyan D., Varmus H. Seeding and propagation of untransformed mouse mammary cells in the lung. Science 2008, 321:1841-1844.
99. Politi K., Pao W. How genetically engineered mouse tumor models provide insights into human cancers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2011, 29:2273-2281.
100. Ponomarev V., Doubrovin M., Serganova I., Vider J., Shavrin A., Beresten T., Ivanova A., Ageyeva L., Tourkova V., Balatoni J., Bornmann W., Blasberg R., Gelovani Tjuvajev J. A novel triple-modality reporter gene for whole-body fluorescent, bioluminescent, and nuclear noninvasive imaging. European Journal of Nuclear Medicine and Molecular Imaging 2004, 31:740-751.
101. Price J.E., Polyzos A., Zhang R.D., Daniels L.M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Research 1990, 50:717-721.
102. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456:593-598.
103. Ramaswamy S., Ross K.N., Lander E.S., Golub T.R. A molecular signature of metastasis in primary solid tumors. Nature Genetics 2003, 33:49-54.
104. Rampetsreiter P., Casanova E., Eferl R. Genetically modified mouse models of cancer invasion and metastasis. Drug Discovery Today. Disease Models 2011, 8:67-74.
105. Rangarajan A., Weinberg R.A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nature Reviews Cancer 2003, 3:952-959.
106. Rapp U.R., Korn C., Ceteci F., Karreman C., Luetkenhaus K., Serafin V., Zanucco E., Castro I., Potapenko T. MYC is a metastasis gene for non-small-cell lung cancer. PloS One 2009, 4:e6029.
107. Reiske H.R., Kao S.C., Cary L.A., Guan J.L., Lai J.F., Chen H.C. Requirement of phosphatidylinositol 3-kinase in focal adhesion kinase-promoted cell migration. The Journal of Biological Chemistry 1999, 274:12361-12366.
108. Rubio-Viqueira B., Hidalgo M. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients. Clinical Pharmacology and Therapeutics 2009, 85:217-221.
109. Sanchez P.V., Perry R.L., Sarry J.E., Perl A.E., Murphy K., Swider C.R., Bagg A., Choi J.K., Biegel J.A., Danet-Desnoyers G., Carroll M. A robust xenotransplantation model for acute myeloid leukemia. Leukemia: Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2009, 23:2109-2117.
110. Scheel C., Onder T., Karnoub A., Weinberg R.A. Adaptation versus selection: the origins of metastatic behavior. Cancer Research 2007, 67:11476-11479. discussion 11479-11480.
111. Schoeffner D.J., Matheny S.L., Akahane T., Factor V., Berry A., Merlino G., Thorgeirsson U.P. VEGF contributes to mammary tumor growth in transgenic mice through paracrine and autocrine mechanisms. Laboratory Investigation: a Journal of Technical Methods and Pathology 2005, 85:608-623.
112. Sethi N., Kang Y. Unravelling the complexity of metastasis - molecular understanding and targeted therapies. Nature Reviews Cancer 2011, 11:735-748.
113. Shaw L.M. Tumor cell invasion assays. Methods in Molecular Biology 2005, 294:97-105.
114. Shibue T., Weinberg R.A. Metastatic colonization: settlement, adaptation and propagation of tumor cells in a foreign tissue environment. Seminars in Cancer Biology 2011, 21:99-106.
115. Siegel P.M., Shu W., Cardiff R.D., Muller W.J., Massague J. Transforming growth factor beta signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:8430-8435.
116. Stoker M., Perryman M. An epithelial scatter factor released by embryo fibroblasts. Journal of Cell Science 1985, 77:209-223.
117. Sweeney T.J., Mailander V., Tucker A.A., Olomu A.B., Zhang W., Cao Y., Negrin R.S., Contag C.H. Visualizing the kinetics of tumor-cell clearance in living animals. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:12044-12049.
118. Tuveson D.A., Jacks T. Technologically advanced cancer modeling in mice. Current Opinion in Genetics & Development 2002, 12:105-110.
119. Tuveson D.A., Zhu L., Gopinathan A., Willis N.A., Kachatrian L., Grochow R., Pin C.L., Mitin N.Y., Taparowsky E.J., Gimotty P.A., Hruban R.H., Jacks T., Konieczny S.F. Mist1-KrasG12D knock-in mice develop mixed differentiation metastatic exocrine pancreatic carcinoma and hepatocellular carcinoma. Cancer Research 2006, 66:242-247.
120. van 't Veer L.J., Dai H., van de Vijver M.J., He Y.D., Hart A.A., Mao M., Peterse H.L., van der Kooy K., Marton M.J., Witteveen A.T., Schreiber G.J., Kerkhoven R.M., Roberts C., Linsley P.S., Bernards R., Friend S.H. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
121. van de Vijver M.J., He Y.D., van't Veer L.J., Dai H., Hart A.A., Voskuil D.W., Schreiber G.J., Peterse J.L., Roberts C., Marton M.J., Parrish M., Atsma D., Witteveen A., Glas A., Delahaye L., van der Velde T., Bartelink H., Rodenhuis S., Rutgers E.T., Friend S.H., Bernards R. A gene-expression signature as a predictor of survival in breast cancer. The New England Journal of Medicine 2002, 347:1999-2009.
122. Vantyghem S.A., Allan A.L., Postenka C.O., Al-Katib W., Keeney M., Tuck A.B., Chambers A.F. A new model for lymphatic metastasis: development of a variant of the MDA-MB-468 human breast cancer cell line that aggressively metastasizes to lymph nodes. Clinical & Experimental Metastasis 2005, 22:351-361.
123. Vignjevic D., Fre S., Louvard D., Robine S. Conditional mouse models of cancer. Handbook of Experimental Pharmacology 2007, 263-287.
124. Wang S., Gao J., Lei Q., Rozengurt N., Pritchard C., Jiao J., Thomas G.V., Li G., Roy-Burman P., Nelson P.S., Liu X., Wu H. Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 2003, 4:209-221.
125. Willecke M., Toggweiler J., Basler K. Loss of PI3K blocks cell-cycle progression in a drosophila tumor model. Oncogene 2011, 30:4067-4074.
126. Wyckoff J.B., Jones J.G., Condeelis J.S., Segall J.E. A critical step in metastasis: in vivo analysis of intravasation at the primary tumor. Cancer Research 2000, 60:2504-2511.
127. Wyckoff J.B., Segall J.E., Condeelis J.S. The collection of the motile population of cells from a living tumor. Cancer Research 2000, 60:5401-5404.
128. Xie W., Evans R.M. Pharmaceutical use of mouse models humanized for the xenobiotic receptor. Drug Discovery Today 2002, 7:509-515.
129. Yang J., Mani S.A., Donaher J.L., Ramaswamy S., Itzykson R.A., Come C., Savagner P., Gitelman I., Richardson A., Weinberg R.A. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004, 117:927-939.
130. Yang M., Baranov E., Jiang P., Sun F.X., Li X.M., Li L., Hasegawa S., Bouvet M., Al-Tuwaijri M., Chishima T., Shimada H., Moossa A.R., Penman S., Hoffman R.M. Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases. Proceedings of the National Academy of Sciences of the United States of America 2000, 97:1206-1211.
131. Zeisberg M., Neilson E.G. Biomarkers for epithelial-mesenchymal transitions. The Journal of Clinical Investigation 2009, 119:1429-1437.
132. Zhong C., Saribekyan G., Liao C.P., Cohen M.B., Roy-Burman P. Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis. Cancer Research 2006, 66:2188-2194.
133. Zhou Z., Flesken-Nikitin A., Corney D.C., Wang W., Goodrich D.W., Roy-Burman P., Nikitin A.Y. Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer. Cancer Research 2006, 66:7889-7898.